Literature DB >> 18837000

Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.

Jeoung Hyun Kim1, Jeong Kon Kim, Bum-Woo Park, Namkug Kim, Kyoung-Sik Cho.   

Abstract

PURPOSE: To evaluate diagnostic performance of apparent diffusion coefficient (ADC) in differentiating prostate cancer from noncancerous tissue according to anatomical region.
MATERIALS AND METHODS: In 47 patients with diffusion-weighted-MR (b-value, 0 and 1000 sec/mm2) on a 1.5 T unit, ADCs were measured in prostate cancer and in three noncancerous tissues (transitional zone, peripheral zone, and prostatic base). Diagnostic performance of ADC for differentiating cancer from noncancerous tissue was evaluated using receiver-operating-characteristics (ROC) analysis.
RESULTS: Mean ADC of prostate cancer (0.963x10(-3) mm2/s) was lower than those of all noncancerous tissues (P<0.001). In noncancerous tissue, ADC differed according to anatomical region (peripheral zone, 1.572x10(-3) mm2/sec; transitional zone, 1.441x10(-3) mm2/sec; prostatic base, 1.146x10(-3) mm2/sec) (P<0.01). ADC was lower in prostate cancer than in all noncancerous tissues in 34 (72%) patients. Area under the ROC curve for differentiating cancer from noncancerous tissue in prostatic base (0.725) was less than those for differentiating cancer from noncancerous tissue in peripheral (0.952) and transitional zones (0.906) (P<0.05). Sensitivity differed according to anatomical region (peripheral zone, 98%; transitional zone, 82%; prostatic base, 66%) (P<0.05).
CONCLUSION: Variable ADC in noncancerous tissue according to anatomical region may limit diagnostic performance of ADC for cancer detection. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18837000     DOI: 10.1002/jmri.21513

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  21 in total

1.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation.

Authors:  Kazuhiro Katahira; Taro Takahara; Thomas C Kwee; Seitaro Oda; Yasuko Suzuki; Shoji Morishita; Kosuke Kitani; Yasuyuki Hamada; Mitsuhiko Kitaoka; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2010-07-18       Impact factor: 5.315

Review 2.  Diffusion weighted imaging in prostate cancer.

Authors:  Cher Heng Tan; Jihong Wang; Vikas Kundra
Journal:  Eur Radiol       Date:  2010-10-09       Impact factor: 5.315

3.  Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.

Authors:  Thomas de Perrot; Olivier Rager; Max Scheffler; Martin Lord; Marc Pusztaszeri; Christophe Iselin; Osman Ratib; Jean-Paul Vallee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

Review 4.  Advancements in MR imaging of the prostate: from diagnosis to interventions.

Authors:  David Bonekamp; Michael A Jacobs; Riham El-Khouli; Dan Stoianovici; Katarzyna J Macura
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

Review 5.  Diffusion-weighted imaging of focal renal lesions: a meta-analysis.

Authors:  E A Lassel; R Rao; C Schwenke; S O Schoenberg; H J Michaely
Journal:  Eur Radiol       Date:  2013-09-10       Impact factor: 5.315

6.  Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging.

Authors:  Arda Kayhan; Xiaobing Fan; Jacob Oommen; Aytekin Oto
Journal:  World J Radiol       Date:  2010-05-28

7.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.

Authors:  Satish E Viswanath; Nicholas B Bloch; Jonathan C Chappelow; Robert Toth; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2012-02-15       Impact factor: 4.813

8.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Authors:  Aytekin Oto; Arda Kayhan; Yulei Jiang; Maria Tretiakova; Cheng Yang; Tatjana Antic; Farid Dahi; Arieh L Shalhav; Gregory Karczmar; Walter M Stadler
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

Review 9.  Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.

Authors:  Michael A Jacobs; Ronald Ouwerkerk; Kyle Petrowski; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12

Review 10.  Multidisciplinary functional MR imaging for prostate cancer.

Authors:  Jeong Kon Kim; Yun-Jin Jang; Gyunggoo Cho
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.